WHAT YOU NEED TO KNOW We’re two months into the new year and the Coalition Against Patent Abuse (CAPA) is continuing to highlight why Congress should act to address abuses of the U.S. patent system. Many Big Pharma companies regular engage in tactics that can extend government-granted monopolies and illegitimately keep drug prices high for […]

Continue Reading

WHAT YOU NEED TO KNOW CAPA Continues “Spot-On Savings” Mini-Series To Show How The IPR Process Can Generate Savings For Millions Of Patients & The U.S. Healthcare System. Part II: IPR & Zytiga – Competition Matters – Here, CAPA looks at how the IPR proceeding for the prostate cancer medicine Zytiga accelerated patient access to generic […]

Continue Reading

Part II: IPR & Zytiga – Competition Matters The rising costs of prescription drugs is one of the most important issues to Americans, especially as millions continue to grapple with financial hardships brought on by the coronavirus pandemic. Today, the U.S. pays some of the highest prices in the world for prescription drugs thanks in […]

Continue Reading